Advertisement

SARS: Collaboration and Resistance

  • Jeremy Youde
Chapter

Abstract

Severe acute respiratory syndrome (SARS) is a disease of many firsts. It was the first international disease epidemic of the twenty-first century. It was the first time this novel Coronavirus had been found in humans. It was the international community’s first true public health challenge in the new century. Finally, it was the first disease that globalization visibly both exacerbated its spread in a short period of time and contributed significantly to its end. Its emergence posed multiple, unique challenges to an international community still struggling to devise an appropriate response to the threat of epidemic diseases.

Keywords

International Community Severe Acute Respiratory Syndrome Chinese Government Chinese Communist Party Severe Acute Respiratory Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

  1. 1.
    David P. Fidler, SARS, Governance, and the Globalization of Disease (Houndsmill: Palgrave Macmillan, 2004), 5.CrossRefGoogle Scholar
  2. 2.
    WHO, WHO Guidelines for the Global Surveillance of Severe Acute Respiratory Syndrome (SARS). Updated Recommendations, October 2004 (Geneva: WHO, 2004).Google Scholar
  3. 3.
    Megan Murray, “The Epidemiology of SARS”, in SARS in China: Prelude to a Pandemic? Arthur Kleinman and James L. Watson, eds. (Stanford: Stanford University Press, 2003), 23–24.Google Scholar
  4. 5.
    Lauren J. Stockman, Richard Bellamy, and Paul Gardner, “SARS: Systematic Review of Treatment Effects”, PLoS Medicine 3 (2006), 1525.CrossRefGoogle Scholar
  5. 8.
    Karl Taro Greenfield, China Syndrome: The True Story of the 21st Century’s First Great Pandemic, (New York: HarperCollins, 2006), 42–43.Google Scholar
  6. 14.
    Tony Saich, “Is SARS China’s Chernobyl or Much Ado about Nothing?” in SARS in China: Prelude to a Pandemic? Arthur Kleinman and James L. Watson, eds. (Stanford, CA: Stanford University Press, 2003), 76.Google Scholar
  7. 16.
    Alan Schnur, “The Role of the World Health Organization in Combating SARS, Focusing on the Efforts in China”, in SARS in China: Prelude to a Pandemic? Arthur Kleinman and James L. Watson, eds. (Stanford, CA: Stanford University Press, 2003), 36.Google Scholar
  8. 30.
    Bernd Sebastian Kamps and Christian Hoffmann, eds., SARS Reference, (Paris: Flying Publishers, 2006). http://www.sarsreference.com/sarsref/timeline.htm (accessed September 1, 2008).Google Scholar
  9. 33.
    Cecilia Cheng, “To Be Paranoid Is the Standard? Panic Responses to SARS Outbreak in the Hong Kong Special Administrative Region”, Asian Perspective 28 (2004), 71.Google Scholar
  10. 35.
    Joan Kaufman, “SARS and China’s Health-Care Response: Better to Be Both Red and Expert!” in SARS in China: Prelude to a Pandemic? Arthur Kleinman and James L. Watson, eds. (Stanford, CA: Stanford University Press, 2003), 56.Google Scholar
  11. 39.
    Xiaohong Xu, “The Impact of SARS on China”, Seton Hall Journal of Diplomacy and International Relations 4 (2003), 49.Google Scholar
  12. 44.
    Yanzhong Huang, “The Politics of China’s SARS crisis”, Harvard Asia Quarterly 7 (2003), 13.Google Scholar
  13. 53.
    Jonathan Schwartz and R. Gregory Evans, “Causes of Effective Policy Implementation: China’s Public Health Response to SARS”, Journal of Contemporary China 16 (2007), 197–199.CrossRefGoogle Scholar
  14. 64.
    Paul Thiers, “Risk Society Comes to China: SARS, Transparency, and Public Accountability”, Asian Perspective 27 (2003), 247.Google Scholar
  15. 67.
    Brian Doberstyn, “What Did We Learn from SARS?” in SARS: How a Global Epidemic Was Stopped, WHO, ed. (Geneva: WHO, 2006), 247.Google Scholar
  16. 68.
    Timothy J. Brookes, Behind the Mask: How the World Survived SARS, the First Epidemic of the Twenty-First Century, (Washington, D.C.: American Public Health Association Publications, 2005), 162.Google Scholar
  17. 69.
    National Intelligence Council, SARS: Down but Still a Threat (Washington, D.C.: National Intelligence Council, 2003). http://www.dni.gov/nic/special_sarsthreat.htm (accessed September 2, 2008).Google Scholar
  18. 70.
    Matthew K. Wynia, “Ethics and Public Health Emergencies: Restrictions on Liberty”, American Journal of Bioethics 7 (2007), 2.CrossRefGoogle Scholar
  19. 71.
    James Lawson and Teng Xu, “SARS in Canada and China: Two Approaches to Emergency Health Policy”, Governance 20 (2007), 214–215.CrossRefGoogle Scholar
  20. 72.
    Thomas Abraham, Twenty-First Century Plague: The Story of SARS (Baltimore, MD: The Johns Hopkins University Press, 2005), 24.Google Scholar
  21. 75.
    Robert J. Blendon, John M. Benson, Catherin M. DesRoches, Elizabeth Raleigh, and Kalahn Taylor-Clark, “The Public’s Response to Severe Acute Respiratory Syndrome in Toronto and the United States”, Clinical Infectious Diseases 38 (2004), 925–931.CrossRefGoogle Scholar
  22. 76.
    L. James, N. Shindo, J. Cutter, S. Ma, and S.K. Chew, “Public Health Measures Implemented during the SARS Outbreak in Singapore, 2003”, Public Health 120 (2006), 24.CrossRefGoogle Scholar
  23. 88.
    Mely Caballero-Anthony, “SARS in Asia: Crisis, Vulnerabilities, and Regional Responses”, Asian Survey 45 (2005), 485.CrossRefGoogle Scholar
  24. 89.
    Jacques deLisle, “SARS, Greater China, and the Pathologies of Globalization and Transition”, Orbis 47 (2003), 598–599.CrossRefGoogle Scholar
  25. 92.
    Jason W. Sapsin, Lawrence O. Gostin, Jon S. Vernick, Scott Burris, and Stephen P. Teret, “SARS and International Legal Preparedness”, Temple Law Review 77 (2004), 160–161.Google Scholar
  26. 98.
    Lawrence O. Gostin, Ronald Bayer, and Amy L. Fairchild, “Ethical and Legal Challenges Posed by Severe Acute Respiratory Syndrome: Implications for the Control of Severe Infectious Disease Threats”, Journal of the American Medical Association 290 (2007), 3230.Google Scholar
  27. 104.
    Stella R. Quah and Lee Hin-Peng, “Crisis Prevention and Management during SARS Outbreak, Singapore”, Emerging Infectious Disease 10 (2004), 366.Google Scholar
  28. 106.
    Peggy Teo, Brenda S.A. Yeoh, and Shir Nee Ong, “SARS in Singapore: Surveillance Strategies in a Globalizing City”, Health Policy 72 (2005), 281.CrossRefGoogle Scholar
  29. 114.
    Chua Beng Huat, “SARS Epidemic and the Disclosure of the Singaporean Nation”, Cultural Politics 2 (2006), 85.CrossRefGoogle Scholar
  30. 122.
    Sarah Sanford and S. Harris Ali, “The New Public Health Hegemony: Response to Severe Acute Respiratory Syndrome (SARS) in Toronto”, Social Theory and Health 3 (2005), 119.CrossRefGoogle Scholar
  31. 123.
    See John Barry, The Great Influenza: The Epic Story of the Deadliest Epidemic in History (New York: Viking, 2004)Google Scholar
  32. David M. Oshinsky, Polio: An American Story (New York: Oxford University Press, 2005).Google Scholar
  33. 128.
    Ho-fung Hung, “The Politics of SARS: Containing the Perils of Globalization by More Globalization”, Asian Perspective 28 (2004), 29–31.Google Scholar
  34. 130.
    Laura Eichelberger, “SARS and New York’s Chinatown: The Politics of Risk and Blame during an Epidemic”, Social Science and Medicine 65 (2007), 1284–1295.CrossRefGoogle Scholar
  35. 131.
    Peter Baehr, “Susan Sontag, Battle Language, and the Hong Kong SARS Outbreak of 2003”, Economics and Society 35 (2006), 42–64.CrossRefGoogle Scholar
  36. 133.
    David P. Fidler, “The Return of the Fourth Horseman: Emerging Infectious Diseases and International Law”, Minnesota Law Review 81 (1997), 775–776.Google Scholar
  37. 139.
    David P. Fidler, “Germs, Governance, and Global Public Health in the Wake of SARS”, Journal of Clinical Investigation 113 (2004), 802.CrossRefGoogle Scholar

Copyright information

© Jeremy Youde 2010

Authors and Affiliations

  • Jeremy Youde

There are no affiliations available

Personalised recommendations